Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Who May Qualify: - Patient Inclusion Criteria - Hospitalized patients (age ≥ 18 years) with high-risk AML defined as: - Patients with new diagnosis ≥ 60 years of age - An antecedent hematologic disorder - Therapy related-disease - Relapsed or primary refractory AML - Within five business days of initiating therapy with either a) intensive chemotherapy (7+3) or modification of this regimen on a clinical trial, or a similar intensive regimen requiring prolonged hospitalization; or b) hypomethylating agents +/- additional agents or modification of this regimen on a clinical trial. - Caregiver Inclusion Criteria - Adult (≥18 years) relative or friend of a participating patient who the patient identifies as living with or has in-person contact with them at least twice per week. Who Should NOT Join This Trial: \- Patient Exclusion Criteria - Patients with a diagnosis of acute promyelocytic leukemia (APML) - Patients with AML receiving supportive care alone - Patients with psychiatric or cognitive conditions which the treating clinicians believe prohibits willing to sign a consent form or compliance with study procedures - Patients seen by a palliative care clinician (MD, DO, APP) during two previous hospitalizations in the six months prior to enrollment - Patients expected to be discharged within 2 days Always talk to your doctor about whether this trial is right for you.